Healthcare & Life Sciences

Beyond Barriers Therapeutics

alive

About

Beyond Barriers Therapeutics is developing BBT-101, an intranasal drug therapy intended for rapid, field-deployable treatment of mild and moderate brain injuries such as concussions.

Explore Beyond Barriers Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.